Drugmakers and Research Partners Have Until October 30 to Apply for FDA Pilot Targeting First Human Trials
The FDA finalized its Expedited IND Pilot and is taking applications through Oct. 30. What changed, what an IND is, and why approvals are not faster.
Medical Daily ·